Skip to main content
Advertisement

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

Novel Therapies for Hidradenitis Suppurativa Produce Rapid, Deepening Responses

Novel Therapies for Hidradenitis Suppurativa Produce Rapid, Deepening Responses
ShareXFacebook

(MedPage Today) -- DENVER -- Two therapeutic candidates for severe hidradenitis suppurativa (HS) achieved major responses that proved durable in randomized trials reported here. The IL-17A/F inhibitor sonelokimab achieved at least 75% skin clearance...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Mono and MS: New Research Deepens Link
MedPage Today

Mono and MS: New Research Deepens Link

(MedPage Today) -- Infectious mononucleosis (IM) with confirmed Epstein-Barr virus (EBV) was associated with a more than threefold increase in incident multiple sclerosis (MS), a population-based retrospective study showed. Over follow-up periods...

Read more →
Trump's Budget Again Calls for Billions in NIH Cuts
MedPage Today

Trump's Budget Again Calls for Billions in NIH Cuts

(MedPage Today) -- Proposed cuts of $5 billion in NIH funding and $129 million to the Agency for Healthcare Research and Quality (AHRQ) were included in the Trump administration's fiscal year 2027 budget. In all, "the budget requests $111.1 billion...

Read more →
Advertisement